PureTech Health forms Seaport Therapeutics with $100M
Ticker: PTCHF · Form: 6-K · Filed: Oct 21, 2024 · CIK: 1782999
| Field | Detail |
|---|---|
| Company | Puretech Health PLC (PTCHF) |
| Form Type | 6-K |
| Filed Date | Oct 21, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $225 Million |
| Sentiment | neutral |
Sentiment: neutral
Topics: new-entity, rare-diseases, funding, biotech
Related Tickers: PRTC
TL;DR
PureTech Health launches Seaport Therapeutics for rare diseases, injecting $100M to kickstart development.
AI Summary
On October 21, 2024, PureTech Health plc announced the formation of a new entity, Seaport Therapeutics. This new company will focus on developing treatments for rare immunological diseases. PureTech Health plc has committed an initial $100 million in funding to Seaport Therapeutics.
Why It Matters
The creation of Seaport Therapeutics signifies PureTech Health's strategic expansion into rare disease treatments, potentially unlocking new therapeutic avenues and market opportunities.
Risk Assessment
Risk Level: medium — The formation of a new entity and its focus on rare diseases introduces inherent risks associated with drug development and market adoption.
Key Numbers
- $100M — Initial Funding (Committed by PureTech Health plc to Seaport Therapeutics for development.)
Key Players & Entities
- PureTech Health plc (company) — Registrant and parent company
- Seaport Therapeutics (company) — Newly formed entity
- October 21, 2024 (date) — Date of press release and announcement
- $100 million (dollar_amount) — Initial funding for Seaport Therapeutics
FAQ
What is the primary focus of the newly formed Seaport Therapeutics?
Seaport Therapeutics will focus on developing treatments for rare immunological diseases.
Who is providing the initial funding for Seaport Therapeutics?
PureTech Health plc is providing the initial funding.
What is the amount of the initial funding for Seaport Therapeutics?
The initial funding is $100 million.
When was the formation of Seaport Therapeutics announced?
The announcement was made on October 21, 2024.
What is the ticker symbol for PureTech Health plc?
PureTech Health plc trades on the LSE and Nasdaq under the ticker symbol PRTC.
Filing Stats: 257 words · 1 min read · ~1 pages · Grade level 17 · Accepted 2024-10-21 16:30:27
Key Financial Figures
- $225 Million — nded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
Filing Documents
- d891953d6k.htm (6-K) — 9KB
- d891953dex991.htm (EX-99.1) — 21KB
- 0001193125-24-240439.txt ( ) — 31KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PURETECH HEALTH PLC Date: October 21, 2024 By: /s/ Bharatt Chowrira Name: Bharatt Chowrira Title: Chief Executive Officer